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ABSTRACT: Overabundant populations of elk
(Cervus elaphus) are a significant concern in
some areas of the western United States
because of potential ecologic damage and
spread of brucellosis to domestic livestock.
Brucella abortus is transmitted among elk
through direct contact with aborted fetuses,
placentas and associated fluids, or postpartum
discharge of infected animals. Because trans-
mission of brucellosis is dependent on preg-
nancy, contraception of cows could be used for
both disease and population management. The
objective of this study was to evaluate the
contraceptive efficacy of a gonadotropin-releas-
ing hormone vaccine (GonaConTM) in female
elk. In September 2004, cows were given a
single immunization of either 1,000 mg (n512)
or 2,000 mg (n510) of GonaConTM and com-
pared with a group of adjuvant-treated controls
(n515). In November 2004, 2005, and 2006,
cows were grouped with bulls for the breeding
season. Blood samples were taken in February
2005 and March 2006 and 2007 for pregnancy
testing, progesterone assays, and antibody
titers. For cows given 1,000 mg GonaConTM
the percentages that were infertile for 2005,
2006, and 2007 were 86%, 90%, and 100%,
respectively, compared with 90%, 100%, and
100% for cows given 2,000 mg GonaConTM.
Rates of infertility for control cows were 23%,
28%, and 0% (P,0.0001). The results indicated
that either dose of GonaConTM prevented
pregnancy of elk cows for at least 3 yr. We
concluded that GonaConTM use for population
management of elk warrants consideration as
part of a strategy to control brucellosis.
Key words: Elk, Cervus elaphus, GnRH
vaccine, GonaConTM, immunocontraception.
INTRODUCTION
In previous studies, we have demon-
strated that the gonadotropin-releasing
hormone (GnRH) vaccine, GonaConTM,
is highly effective for preventing pregnan-
cy in white-tailed deer (Odocoileus virgi-
nianus; Miller et al., 2000, 2007), feral
horses (Equus caballus; Killian et al., 2004,
2006a), domestic and feral swine (Sus
scrofa; Miller et al., 2003; Killian et al.,
2006c), bison (Bison bison; Miller and
Drew, 2004), as well as several other
species (Levy et al., 2004; Miller and
Killian, 2004; Nash et al., 2004). In female
deer and horses, a single intramuscular
injection of GonaConTM was effective for
up to 5 yr (Killian et al., 2006b; Miller
et al. 2007). GonaConTM stimulates the
immune system to produce antibodies
against GnRH, a small peptide protein
produced by the hypothalamus. When
sufficient antibody is present, the antibody
complexes with, and inactivates, GnRH
and prevents it from stimulating repro-
ductive hormone and gamete production.
The result is an infertile animal that
remains in this state until the concentra-
tion of antibody declines to an ineffective
level. In safety and toxicity studies with
white-tailed deer, GonaConTM had no
adverse effects based on blood chemistry,
postmortem, and histopathology evalua-
tions (Killian et al., 2006a).
Contraceptive vaccines can be used as a
tool to manage overabundant wildlife
populations where lethal means of man-
agement are not feasible (Fagerstone et
al., 2002), such as in national parks or
urban or suburban areas. The contracep-
tive management strategy works best
when populations have been reduced to
the desired level before the use of
contraceptive vaccines.
Overabundant wildlife populations also
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increase the potential for disease trans-
mission. Brucellosis is a zoonotic disease
transmitted among elk, bison, and domes-
tic livestock by direct contact with aborted
fetuses, placentas, and associated fluids of
infected animals. The disease is present in
free-ranging elk and bison in the Greater
Yellowstone Area (GYA; Cheville et al.,
1998). Because the ranges of elk and bison
may overlap with grazing cattle, there is
considerable concern the disease will be
spread to livestock. Although elk cows,
under natural conditions, typically seek
isolation during calving, winter feeding of
elk and livestock has increased congrega-
tion and commingling, resulting in in-
creased opportunities for disease trans-
mission.
Miller and Drew (2004) and Killian et al.
(2006c) introduced the concept that bru-
cellosis transmission could be limited by
preventing pregnancy in conjunction with a
Brucella vaccination campaign in bison and
feral swine. Reversible contraception could
prevent pregnancy, and thus abortion, of
Brucella-infected elk until they cleared the
bacteria. We undertook the present study
to evaluate the contraceptive efficacy of
two doses of GonaConTM, given as a single
injection to captive female elk.
The study was conducted at the Sybille
Wildlife Research Unit of the Wyoming
Game and Fish Department (Wheatland,
Wyoming, USA; 41u4594799N, 105u2293699W)
from 2004–2007. In February 2002, female
elk calves were captured in corral traps at
the National Elk Refuge (Jackson, Wyom-
ing, USA) and transported to Sybille. There
elk were housed in 0.4-ha corrals and fed
alfalfa hay supplemented with a pelleted
ration. Water and a trace mineral block
were provided ad libitum. Chronic wasting
disease has existed in the Sybille facility for
more than 15 yr and captive cervids often
contract the disease, probably from a
contaminated environment (Miller et al.,
2004) Chronic wasting disease has not been
found where the calves were captured
(Kreeger, unpubl. data).
The GonaConTM vaccine consisted of
GnRH peptide conjugated to Keyhole
Limpet Hemocyanin (KLH; Miller et al.,
2000) made into an emulsion with Adju-
VacTM adjuvant (Pocatello Supply Depot,
Pocatello, Idaho, USA). In September
2004, 12 cows received a 1-ml injection
of 1,000 mg of GonaConTM, 10 cows
received a 1-ml injection of 2,000 mg of
GonaConTM, 13 control cows received a 1-
ml injection of the adjuvant-buffer emul-
sion, and two control cows were untreated.
Treatment groups were housed in individ-
ual pens. Intramuscular injections were
delivered remotely by darts equipped with
biodegradable barbs (Pneu-Dart, Inc.,
Williamsport, Pennsylvania, USA).
At the beginning of November 2004,
2005, and 2006, cows were grouped with
bulls for breeding. Bulls were exchanged
among the cow groups every other week
for 3 mo to maximize conception. Blood
samples were collected in February or
March of 2005, 2006, and 2007 from the
jugular vein while cows were restrained in
a chute. After clotting, the serum was
harvested by centrifugation and kept
stored frozen at 220 C until assay. Serum
was used to determine antibody titers to
GnRH and progesterone concentration
using methods described elsewhere (Mil-
ler et al., 2000). Assays for pregnancy-
specific protein B were performed by
BioTracking (Moscow, Idaho, USA).
Significant differences among treat-
ments and controls for percentages of
infertility and mortality were determined
by chi-square. Differences between treat-
ments for antibody titers and serum
progesterone concentrations were deter-
mined by Student’s t-test.
Antibody titers for cows treated with
1,000 mg of GonaConTM averaged 1.04 3
105 at 5 mo after the immunization.
Average titers were maintained for the
1,000 mg group at 7.8 and 8.5 3 104 in
2006 and 2007, respectively (Fig. 1). Cows
receiving the 2,000-mg dose of Gona-
ConTM had an average titer of 1.29 3
105 in 2005, which compared with average
titers of 1.48 and 1.44 3 105 (P50.016) in
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2006 and 2007 (Fig 1). These data sug-
gested that there may be an advantage to
using the 2,000-mg dose of GonaConTM
over the 1,000-mg dose to provide signif-
icantly greater titers.
Compared with the control animals,
both doses of the GonaConTM vaccine
were highly effective in preventing preg-
nancy in elk cows throughout the entire
study (P,0.0001). Annual infertility rates
were lowest in the control animals where
27% (4/15), 25% (2/8), and 0% (0/6) were
infertile in 2005, 2006, and 2007, respec-
tively (Fig. 2). In contrast, 92% (11/12),
90% (9/10), and 100% (8/8) were infertile
in the group receiving 1,000 mg of Gona-
FIGURE 1. Average anti-GnRH titers for serum samples taken from control elk cows and from 1,000-mg,
and 2,000-mg treated elk cows in February or March of 2005, 2006, and 2007, following a single vaccination
with GonaConTM or a control vehicle in September of 2004.
FIGURE 2. Average rates of infertility for control elk cows and for 1,000-mg and 2,000-mg treated elk cows for
breeding seasons in 2005, 2006, and 2007, following a single vaccination with GonaConTM in September of 2004.
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ConTM, and 90% (9/10), 100% (8/8), and
100% (6/6) were infertile in the group
receiving the 2,000-mg dose of Gona-
ConTM (Fig. 2).
Although antibody titers were greater in
cows treated with the 2,000-mg dose of
GonaConTM, there were no differences in
rates of infertility between the 1,000 mg
and 2,000 mg GonaConTM groups (P5
0.697) over the three breeding seasons
studied. This outcome could change in
future years if there is a greater decline in
titers for the 1,000 mg group compared
with the 2,000 mg group. Taken together,
these results suggested that a single
injection of either dose of GonaConTM
could be used for elk herds where
population management by nonlethal
means is desired.
Although some progesterone is secreted
during the luteal phase of the estrous
cycle, maximal serum concentrations of
progesterone are produced by the corpus
luteum during pregnancy. Control ani-
mals, most of which were pregnant when
the blood samples were taken in February
or March, had greater average concentra-
tions of serum progesterone (P,0.0001)
than cows treated with GonaConTM
(Fig. 3).
Because GonaConTM was a highly effec-
tive immunocontraceptive vaccine for three
breeding seasons, we suggest that it may
prove useful in controlling brucellosis in
infected elk herds’ winter feed grounds in
the GYA-concentrated elk, where the
likelihood of disease transmission is in-
creased. This is supported by the increased
prevalence of Brucella antibodies in feed-
ground elk, which is an order of magnitude
higher than rates in elk not wintering on
feed grounds (Kreeger, 2002). However, elk
concentrated on feed grounds lend them-
selves to a large-scale vaccination program
(Kreeger and Olsen, 2002). A challenge in
managing elk in the GYA is that most herd
sizes are higher than desired management
levels, and hunting has been unable to
reduce elk numbers. Thus, a single-dose,
highly effective immunocontraceptive, like
GonaConTM, would serve to reduce herd
numbers while simultaneously preventing
pregnancy and thus abortion, which would
decrease transmission of brucellosis.
An unfortunate aspect of this study is
that a large number of cows died. Of the
cows that began the study in the fall of
2004, only 20 of the animals were alive
when blood samples were taken in April of
2007. The cause of death in every instance
FIGURE 3. Average serum progesterone concentrations for control elk cows and for 1,000-mg and 2,000-mg
treated elk cows for breeding seasons in 2005, 2006, and 2007, following a single vaccination with GonaConTM
in September of 2004.
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was CWD, diagnosed by immunohisto-
chemistry. Exposure to the CWD prion
was most likely environmental (Miller et
al., 2004) because the facility has experi-
enced continuous losses to CWD for more
than 20 yr (Kreeger, unpubl. data).
Results of this study indicated that
either dose of GonaConTM prevented
pregnancy of elk cows for at least 3 yr.
We concluded that GonaConTM use for
population management of elk warrants
consideration as part of a strategy to
control brucellosis.
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